YZi Labs issued a statement saying that its latest filings show that 10X Capital Asset Management LLC and its affiliates may have held more than 5% of the company's issued common stock by the end of 2025, but have not yet filed the Schedule 13D disclosure required by the U.S. Securities and Exchange Commission (SEC). YZi Labs noted that, according to publicly disclosed warrant exercise data, approximately 2.376 million warrants have been exercised, corresponding to approximately 5.39% of the company's issued shares. YZi Labs stated that it itself has not exercised the relevant warrants, therefore it speculates that these shares mainly come from 10X's affiliated entities. The statement also stated that 10X and its director Hans Thomas have not publicly disclosed their shareholding percentages, nor have they filed the required shareholding disclosure documents. YZi Labs urges the relevant parties to clarify their shareholding situation as soon as possible and disclose whether there is a "related shareholding group" that needs to be disclosed under Section 13(d)(3) of the Securities Exchange Act.